Summary

Buy, $247 target: the price assumes clients leave, yet contract value is growing

InitiationBy Penmark Team
ITBuy$247.12+29%
Page 1 of 24
Equity research | Initiation of coverage | United States
Research and advisory | Initiated | 18 Nov 2026, 08:00 ET
Penmark Team | research@penmarkresearch.com
Gartner, Inc. (NYSE: IT)

Buy, $247 target: the price assumes clients leave, yet contract value is growing

Rating
Initiation
Buy
12-mth target
$247.12
Price, 13 Nov
$192.15
Total return
+28.6%
Base case
$267.31
Bull case
$347.22
Bear case
$146.74

We initiate with a Buy and a 12-month target of $247.12, a 28.6% total return. Gartner sells research and advice to more than 13,000 enterprises. It bills up front, mostly on multi-year contracts. The price assumes clients leave, but contract value (CV, the annual value of subscriptions) is growing again at 2.5%.

  • Contract value has turned. Growth rose from 1.0% to 2.5% in two quarters. One more point of CV growth adds $15.29 a share.
  • EPS grows 16% a year to FY28E, 85% of it from a smaller share count. FY27E adjusted EPS is $17.49 on 58.3m shares, against 61.7m in consensus.
  • The price implies decline. At 11.0x FY27E EPS, CV must fall 0.3% a year to FY35E. We model growth of 3.6%.

What the market is missing. We are 6.9% above consensus on FY27E EPS ($17.49 against $16.36) and 1.1% below on revenue. Our edge is contract value durability. Buybacks explain most of the EPS gap.

Catalysts. The FY27 outlook in early February 2027 settles the margin debate. Further rises in CV would close the valuation gap.

Valuation and target. A discounted cash flow, cross-checked at 15.0x FY27E EPS. Bear, base and bull are $133.40, $243.01 and $315.65 today, weighted 30/50/20. Upside to downside is 3.4x on 12-month values.

Risks. Generative AI replacing seats (−$21.14 a share), a margin reset (−$12.07) and rates above 5% (−$18.72).

Exhibit 2: Earnings grow 16% a year to FY28E, yet the shares trade on 11.0x FY27E
US$m, Dec year endFY24AFY25AFY26EFY27EFY28E
Revenue6,2676,4976,4386,5936,788
Growth y/y6.1%3.7%−0.9%2.4%2.9%
Adj. EBITDA1,5561,6111,6401,6751,744
Margin24.8%24.8%25.5%25.4%25.7%
Net income1,254729943957992
Adj. EPS ($)14.0913.1715.1917.4920.57
Growth y/y–−6.5%15.3%15.2%17.6%
Free cash flow1,3831,1751,2401,2651,306
At $192.15FY24AFY25AFY26EFY27EFY28E
P/E (adj.)13.6x14.6x12.7x11.0x9.3x
EV/EBITDA8.8x8.5x8.3x8.1x7.8x
EV/sales2.2x2.1x2.1x2.1x2.0x
FCF yield11.3%9.6%10.1%10.3%10.6%
Dividend yield0.0%0.0%0.0%0.0%0.0%
Buyback yield6.0%16.2%13.2%13.8%13.8%
Net debt/EBITDA0.3x0.8x0.9x1.2x1.4x
P/E at $247 target17.5x18.8x16.3x14.1x12.0x

Source: Company filings; Penmark Research model, 16 Nov 2026. Adjusted EPS adds back acquired-intangible amortisation and charges but keeps stock pay as a cost; adjusted EBITDA excludes stock pay. FY27E revenue growth of 2.4% includes the divested business in the FY26E base (2.7% excluding it). Right: multiples at the 13 Nov 2026 price; last row at our target. P/B and ROE are not meaningful (negative equity). Shaded = estimates.

Our base case is worth $243; upside is 3.4x downside on 12-month values

Exhibit 3: The base case is worth $267 in 12 months, against $147 in the bear case
$100$150$200$250$300$350Jan-26Jul-26Jan-27Jul-27ActualEstimatesPrice $192Bull $347 (+81%)Base $267 (+39%)Bear $147 (−24%)Target $247 (+29%)

Source: Yahoo Finance weekly closes; Penmark Research model, 16 Nov 2026. Values today rolled forward 12 months at the 10.0% cost of equity (no dividend).

Scenarios and price target basis
Bull$347.22+80.7%20% prob.

Retention above 100%; CV growth 6.5% by FY29E; margin 28%. Worth $315.65 today.

Base$267.31+39.1%50% prob.

CV growth 3.0% in FY27E, 4.0% in FY29E-FY31E, fading to 3.0% by FY35E; margin 26%. Worth $243.01 today.

Bear$146.74−23.6%30% prob.

AI and layoffs cut seats; CV falls 1.5% by FY29E; margin 22%. Worth $133.40 today.

Price target (probability-weighted)$247.12+28.6% price return = Buy
Upside to downside3.4x12-month: $155.07 up / $45.41 down
Exhibit 4: Adjusted EBITDA grows 3% a year; stock pay holds at about 2.6% of sales
US$mFY24AFY25AFY26EFY27EFY28E
Revenue6,2676,4976,4386,5936,788
Adjusted EBITDA1,5561,6111,6401,6751,744
Stock compensation155156171171176
Depreciation and amort.202200184185183
Operating income1,1561,0261,2921,3191,385
Net interest−69−61−88−91−113
Net income1,254729943957992
Adjusted net income1,1039969991,0191,053
Exhibit 5: Free cash flow stays above $1.2bn a year from FY26E, about 1.3 times net income
Cash flow, US$mFY24AFY25AFY26EFY27EFY28E
Cash from operations1,4851,2901,3251,3641,408
Capital expenditure−102−115−85−99−102
Free cash flow1,3831,1751,2401,2651,306
FCF margin22.1%18.1%19.3%19.2%19.2%
FCF / net income1.10x1.61x1.32x1.32x1.32x
Share repurchases7351,9911,6201,6931,689
Closing cash1,9331,7231,4451,000600
Net debt5271,2821,5552,0002,400
Exhibit 6: Negative equity is a result of buybacks, not losses: debt is flat at $3.0bn since FY25
Balance sheet, US$mFY24AFY25AFY26EFY27EFY28E
Cash1,9331,7231,4451,000600
Fees receivable1,6961,6851,7271,7741,826
Goodwill, intangibles3,3403,0772,9942,9152,837
Total assets8,5358,0857,6617,1936,781
Deferred revenue2,7632,8102,8892,9673,054
Long-term debt2,4602,9772,9812,9812,981
Total liabilities7,1767,7657,8247,9378,063
Stockholders' equity1,359320−163−744−1,282
Exhibit 7: Buybacks cut the share count 23% from FY25A to FY27E, lifting EPS faster than profit
Per share and KPIsFY24AFY25AFY26EFY27EFY28E
Diluted shares (m)78.375.665.958.351.2
Adjusted EPS ($)14.0913.1715.1917.4920.57
Reported EPS ($)16.009.6514.3216.4319.38
Dividend per share ($)0.000.000.000.000.00
FCF per share ($)17.6615.5418.8321.7125.52
CV growth, year-end8.0%1.0%2.8%3.0%3.5%
Insights growth6.9%5.0%2.2%2.1%2.4%
Conferences growth15.4%10.5%10.7%7.0%6.0%

Source: Company filings; Penmark Research model, 16 Nov 2026. FY24A–FY25A reported; shaded = estimates (E). Net debt is principal less cash; FY24A uses carrying value. FY26E adjusted EBITDA includes $5m from Digital Markets before its 5 Feb 2026 sale; FY27E onward excludes it. Bold = totals; italic = ratios.

Our FY27E EPS is 6.9% above consensus, mostly because we assume fewer shares

Exhibit 8: Sales grow 3% a year, EPS 16%, and margins hold near 25%
Growth and margins, %FY24AFY25AFY26EFY27EFY28E
Growth y/y
Sales6.1%3.7%−0.9%2.4%2.9%
Adjusted EBITDA4.9%3.5%1.8%2.1%4.2%
Operating income−6.5%−11.3%26.0%2.0%5.0%
Adjusted EPS–−6.5%15.3%15.2%17.6%
Free cash flow31.4%−15.0%5.5%2.1%3.2%
Margins
Adjusted EBITDA24.8%24.8%25.5%25.4%25.7%
Operating income18.4%15.8%20.1%20.0%20.4%
Free cash flow22.1%18.1%19.3%19.2%19.2%
Stock pay / sales2.5%2.4%2.7%2.6%2.6%
Exhibit 9: Leverage stays below 1.5x EBITDA while the price sits at 11x earnings
Leverage and valuationFY24AFY25AFY26EFY27EFY28E
Leverage and cash
Net debt / EBITDA0.3x0.8x0.9x1.2x1.4x
Gross debt / EBITDA–1.9x1.8x1.8x1.7x
EBITDA / net interest22.4x26.6x18.6x18.4x15.4x
FCF / net income1.10x1.61x1.32x1.32x1.32x
At $192.15
P/E (adjusted)13.6x14.6x12.7x11.0x9.3x
EV / EBITDA8.8x8.5x8.3x8.1x7.8x
FCF yield11.3%9.6%10.1%10.3%10.6%
Dividend yield0.0%0.0%0.0%0.0%0.0%
P/E at $247 target17.5x18.8x16.3x14.1x12.0x

Source: Company filings; Penmark Research model, 16 Nov 2026. Growth for FY24A is against FY23A. FY27E sales growth of 2.4% includes the divested business in the FY26E base; excluding it, 2.7%. Net debt is debt principal less cash; FY24A uses carrying value. Returns on equity are not meaningful because equity is negative. Multiples at the 13 Nov 2026 price; last row at our target.

Exhibit 10: We are 6.9% above consensus on FY27E EPS and 1.1% below on revenue
Ours vs consensusFY26EFY27E
Revenue excl. divested, US$m
Penmark estimate6,4196,593
Consensus6,4306,670
Prior-year period6,2706,419
Diff. vs consensus−0.2%−1.1%
Growth y/y (Penmark)+2.4%+2.7%
Adjusted EBITDA excl. divested, US$m
Penmark estimate1,6351,675
Consensus1,6081,679
Prior-year period1,5801,635
Diff. vs consensus+1.7%−0.3%
Growth y/y (Penmark)+3.5%+2.4%
Adjusted EPS, $
Penmark estimate15.1917.49
Consensus14.9916.36
Prior-year period13.1715.19
Diff. vs consensus+1.3%+6.9%
Growth y/y (Penmark)+15.3%+15.2%

Source: Yahoo Finance (revenue, EPS; 16 Nov 2026), MarketScreener (EBITDA; 21 Oct 2026, before the 3 Nov guidance raise); Penmark Research model. FY26E guidance floors: revenue $6,405m, EBITDA $1,615m, EPS $14.65.

Exhibit 11: Adjusted EPS compounds 16% a year to FY28E and sits 6.9% above consensus in FY27E
Consensus$0$5$10$15$20$25FY24AFY25AFY26EFY27EFY28EActualEstimates$14.09$13.17$15.19$17.49$20.57

Source: Company filings (A); Penmark Research estimates (E); Yahoo Finance consensus, 16 Nov 2026. Actual to FY25A, estimates from FY26E; growth FY26E +15.3%, FY27E +15.2%, FY28E +17.6%.

Where the gap comes fromThe $1.13 gap has two parts. Fewer shares add $0.95 (58.3m against about 61.7m). Adjusted net income adds $0.18 ($1,019m against about $1,009m): our 25.4% margin more than offsets revenue $77m below consensus.

Gartner is the cheapest of its peer group on earnings, and the discount is wider than its growth gap explains

Exhibit 12: Gartner trades 51% below the peer P/E despite faster EPS growth
Gartner vs peersITMedianDiff.
Valuation
NTM P/E12.1x24.4x−51%
PEG (P/E / EPS growth)0.74x2.10x−65%
Growth and returns
Revenue CAGR, 3y fcst3.0%6.4%−3.5pp
EPS CAGR, 3y fcst16.3%11.2%+5.1pp
ROIC34.0%17.9%+16.1pp
Risk
Beta, 5y0.910.96−0.05
Net debt / equity14.0%13.0%+1.0pp

Source: S&P Global via StockAnalysis, 13 Nov 2026; Penmark Research model. Peers: Verisk, FactSet, S&P Global, Moody's, MSCI, Thomson Reuters, Broadridge, Morningstar. NTM = next twelve months. ROIC = return on invested capital. Gartner growth is our base case, FY26E–FY29E.

Why the discount may be too wideOur 15.0x target is the peer lower-quartile P/E of 18.8x less 20% for slower growth. It is still 39% below the 24.4x peer median.
Exhibit 13: Four dated events test the thesis over the next 12 months
  • Feb 2027Q4 FY26 results and FY27 outlook. We expect a 25.4% EBITDA margin and EPS of $17.49; consensus is $16.36.
  • May 2027Q1 FY27 results. CV growth near 3% from pricing and steadier retention.
  • Aug 2027Q2 FY27 results. GTS retention above 100% is upside worth $15.29 a share; we hold near 98%.
  • Nov 2027Q3 FY27 results. First full year of the 3% price rise; our target date.

Source: Company calls, 3 Nov 2026; Penmark Research model. Result dates are expected, not confirmed.

Exhibit 14: Three risks cost $12–$21 a share; the main upside adds $15
  • AI replaces seats. CV growth 1.5pt lower each year. Likelihood 35%; −$21.14/share.
  • Rates stay above 5%. Discount rate rises 0.5pt. Likelihood 30%; −$18.72/share.
  • Margin reset in FY27 guide. EBITDA margin 1.0pt lower. Likelihood 30%; −$12.07/share.
  • Upside risk: retention above 100%. CV growth 1.0pt higher. Likelihood 35%; +$15.29/share.
The rating turns Hold ifthe bear case reaches a 59.7% weight (30% today). Values are base-case changes at 13 Nov 2026.

Source: Penmark Research model, 16 Nov 2026.

Exhibit 15: The trailing P/E of 12.5x is 1.8 standard deviations below its 28.7x average
10x20x30x40x50x202220242026Mean 28.7x+1 SD 37.7x−1 SD 19.7x+2 SD 46.7x−2 SD 10.7x12.5x, −1.8 SD

Source: Signals key metrics, 15 quarter-ends with data, Mar 2021 to Sep 2026 (last point 30 Sep 2026; GAAP EPS, last four quarters). Bands are the average and ±1 and ±2 standard deviations (SD) of the series.

Exhibit 16: Peers pay more for each point of ROIC; Gartner earns 34% and is priced as the lowest
10x15x20x25x30x35x10%20%30%40%50%NTM P/EROICITVRSKFDSSPGIMCOMSCITRIBRMORNR² 0.47, n=8

Source: S&P Global via StockAnalysis, 13 Nov 2026; Penmark Research. Fit on the eight peers only.

PART 1 · SUMMARY · 3 THE THESIS IN CHARTS

Six charts show a recovering business priced as a shrinking one

The stock follows contract value, not revenue. Retention is mending, buybacks are shrinking the share count, and the market has cut the multiple more than earnings justify.

Exhibit 17: The share price tracks contract value growth, with a correlation of 0.92
Share price ($, left)CV growth (%, right)$100$200$300$400$5000%2%4%6%8%4Q241Q252Q253Q254Q251Q262Q263Q26

Source: Signals KPIs; Yahoo Finance quarter-end closes. Correlation of levels, eight quarters, Dec 2024 to Sep 2026.

Exhibit 18: Technology retention is mending; business retention has held at 99%
GTS (technology)GBS (business functions)96%98%100%102%104%106%4Q241Q252Q253Q254Q251Q262Q263Q2698%99%

Source: Company supplements and calls, via Signals KPIs. Wallet retention = share of last year's spend still collected.

Exhibit 19: Buybacks cut the weighted share count from 75.6m to 51.2m by FY28E
0m20m40m60m80mFY24AFY25AFY26EFY27EFY28EActualEstimates78.3m75.6m65.9m58.3m51.2m

Source: Company filings (A); Penmark Research estimates (E).

Exhibit 20: We are above consensus on EPS, and below it on FY27E EBITDA and revenue
FY26E EPSFY27E EPSFY26E EBITDAFY27E EBITDAFY26E revenueFY27E revenue+1.3%+6.9%+1.7%−0.3%−0.2%−1.1%

Source: Yahoo Finance consensus (revenue, EPS), 16 Nov 2026; MarketScreener (EBITDA), 21 Oct 2026; Penmark Research model.

Exhibit 21: EV/EBITDA of 8.9x in September 2026 is far below its 19.7x average
5x10x15x20x25x30x202220242026Mean 19.7x+1 SD 26.0x−1 SD 13.4x8.9x, −1.7 SD

Source: Signals, 12 quarter-ends with data, Mar 2021 to Sep 2026 (others not plotted). Last point: trailing, 30 Sep 2026; at $192.15 it is 8.2x (FY26E 8.3x). EV = enterprise value; band = average ±1 standard deviation.

Exhibit 22: A lower multiple, not weaker earnings, explains the $38 fall in the shares
$0$50$100$150$200$250Price, 13 Nov2025EarningsgrowthMultiplechangePrice, 13 Nov2026$230+$8−$46$192

Source: Yahoo Finance; company releases (last-four-quarter adjusted EPS $14.72 to $15.22); Penmark Research analysis. No dividend is paid.

PART 1 · SUMMARY · 4 KEY DEBATES

The market and we disagree on three debates; the AI debate is worth the most

Three disagreements with the market decide the stock. Each one has a dated test within twelve months, and each is worth a number we can state per share.

Exhibit 23: We stand on the other side of the market on all three debates, worth $47 a share
DebateMarket viewPenmark viewEvidenceWhat would change our viewResolves
AI and the seat baseGenerative AI cuts seats, so contract value (CV) growth runs 1.5pt a year lowerCV grows 3.0% in FY27E and 4.0% by FY29E. Value $243.01 a share against $221.87 at the market viewEx-federal CV growth 4.0% (Q4 FY25), 3.3%, 2.8% (Q3 FY26). GTS retention 96% to 98%. Analyst questions on AI: 6 of 48Q4 FY26 print and FY27 guide show CV growth below 2.5%Feb 2027
Margins in FY27Analyst rehiring and sales investment cut the EBITDA margin by 1pt from FY2725.4% in FY27E, 26.0% by FY29E. Value $243.01 against $230.93FY26 margin floor raised three times, to 25.2%. Our FY26E is 25.5%. Rehiring analysts adds cost over several quartersFY27 guide implies a margin below 24.5%Feb 2027
Long-run growthTerminal growth is 2%, because seats stop growing3.0%, set by a price rise of about 3% on a flat seat base. Value $243.01 against $229.02Price rise from 2 Nov 2026 is near 3%, the low end of the 3-4% history. Standard terms heldPrice rise below 2% or retention below 97% through 2027Nov 2027

Source: Penmark Research model, 16 Nov 2026 (values at 13 Nov 2026, base case); company Q3 FY26 call, 3 Nov 2026; Signals KPIs. GTS = Global Technology Sales; ex-federal = excluding US federal government clients.

Exhibit 24: Each market view cuts $12 to $21 from our base-case value per share
Market viewPenmark viewAI and seatsMargins in FY27Long-run growth$222$243$231$243$229$243

Source: Penmark Research model, 16 Nov 2026; base case valued at 13 Nov 2026; each debate changed alone.

How the debates fit the thesis

The AI debate is worth the most and drives the bear case. It is $21 a share, against $12 for margins and $14 for long-run growth. The three gaps sum to $47, which is most of the $51 between our base value and the price. The rating turns Hold only at a 59.7% bear weight.

Why the market may be wrong

The price already assumes shrinking subscriptions. It implies CV growth of −0.3% a year to FY35E, below even the AI bear case of 1.5pt less growth. Today the data point the other way: retention is up and CV growth has risen for two quarters.

Exhibit 25: Two of four dated tests land before August 2027, and the first is the February guide
Feb 2027Q4 FY26 results and FY27guideAI and margins: our EPS$17.49 vs $16.36May 2027Q1 FY27 resultsCV growth near 3% frompricing and steadierretentionAug 2027Q2 FY27 resultsGTS retention above 100%is the bull caseNov 2027Q3 FY27 resultsFirst full year of the 3%price rise

Source: Company calendar pattern of prior years; Penmark Research. Dates are expected, not confirmed.

PART 2 · THE BUSINESS · 5 THE STORY

The market prices Gartner's $5.3bn of subscriptions as if they will shrink

Gartner sells research and advice to more than 13,000 enterprises. Its contract value is growing again, yet the shares trade at 11 times next year's earnings.

1979Founded; 47 years in business
13,000+Enterprises served, FY25
$6.50bnRevenue, FY25
~90Countries and territories, FY25
$12.27bnMarket value, 13 Nov 2026

The scene

On 3 November 2026 Gartner reported contract value growth of 2.5%, up from 1.0% in the first quarter, and raised its profit guidance. The shares still fell 13% that day. Contract value (CV) is the yearly value of all subscription contracts, and the number Gartner treats as most important.

CV grew 8% in 2024 and 1% in 2025. Investors began to ask whether free artificial intelligence (AI) tools could do its analysts' work.

What it actually does

Gartner's analysts study markets and write up what they find. Leaders in technology, marketing and sales pay for that research and for analyst calls. The same clients buy conference places and hire its consultants.

How the money comes in

Clients pay up front and usually renew; over three-quarters of Insights contracts run multiple years. Insights, the subscription arm, was 81% of FY25 revenue (excluding the divested unit) and keeps about 77 cents of each dollar. Revenue grows when clients renew, add seats or accept a price rise, about 3% from 2 November 2026.

Where the story turns

Gartner bought CEB in 2017 in a deal valued at about $3.5bn. Wallet retention among business clients fell from 106% at the end of 2024 to 99% at the end of 2025. Management answered with cash: it sold Digital Markets for $110.0m ($99.8m net cash received) in February 2026 and bought back $1.99bn of stock in FY25.

Why it works, and why it might not

Clients stay because the research is built into how they buy technology. Technology-client wallet retention, the share of last year's spend still collected, rose from 96% at end-2025 to 98% in Q3 FY26. The break point is the AI debate: if AI tools replace seats, CV shrinks, and our bear case values the shares at $133.40.

−0.3%Yearly CV growth to FY35E implied by the share price
At $192.15 the market is paying for subscriptions that shrink slightly every year, while our model has them growing 3.6% a year.Source: Penmark Research model, 16 Nov 2026. If we are right, the gap is worth about $51 a share in the base case.
1 · HOW THEY FIND IT
55Conferences in 2026, plus a direct sales force, reach 13,000+ clients.
2 · WHAT THEY BUY
~$0.4mAverage contract value per client: $5.3bn CV across 13,000+ clients (derived).
3 · WHAT THEY PAY
~3%Annual price rise from 2 Nov 2026, paid up front each year.
4 · WHAT THE COMPANY KEEPS
77%Insights contribution margin; 19.3% of group revenue ends as FCF in FY26E.

One customer, start to finish (illustrative averages from company data; not a single named client). Source: Company filings and calls, 3 Nov 2026; Penmark Research model.

Why the story matters for the stockThe market prices the fear of AI, not two quarters of rising CV growth.
PART 2 · THE BUSINESS · 6 HOW THE COMPANY MAKES MONEY

Insights earns four of every five dollars, and a quarter of revenue turns into EBITDA

Gartner sells one thing, trusted research, in three ways. A subscription is the core, and events and consulting are sold to the same clients.

Exhibit 26: Three deals turned a 1979 start-up into a $6.4bn research business
1979Founded by GideonGartnerStarted with $675,000 ofventure capital1993Back on public marketsSales of $122.5m that year2001Renamed Gartner, Inc.About 10,000 clientorganisations2005META Group boughtAbout $159.8m cash, netof cash acquired2017CEB acquiredAbout $3.5bn enterprisevalue; added abusiness-sales client baseFeb 2026Digital Markets sold$110.0m beforeadjustments ($99.8m netcash received); FY25 revenue of the unit $227m

Source: Company filings and press releases, 1979 to Feb 2026; revenue of the divested unit from the FY25 10-K (Penmark Research model).

Exhibit 27: Of each $1 of FY26E revenue, 25.5 cents is adjusted EBITDA and 14.6 cents is net income
Insights$5,185mConferences$714mConsulting$520mOther (divested)$19mRevenue$6,438mAdjusted EBITDA$1,640mCash operating costs$4,798mStock pay$171mDepreciation and amortisation$184mInterest and other$88mTax$255mNet income$943m

Source: Company filings (9M FY26A); Penmark Research model, FY26E. Adjusted EBITDA includes $5m from the divested unit. Interest and other is net of one-off gains.

Exhibit 28: Technology retention is mending and business retention is holding at 99%
$5.3bn+2.5% y/y; 1.0% in Q1Contract value, Sep 202698%96% at end-2025Technology walletretention99%99% at end-2025Business wallet retention77.6%Q3 FY26Insights contributionmargin$217m+9% y/y, Q3 FY26Consulting backlog

Source: Signals KPIs from company supplements, quarter to 30 Sep 2026.

Exhibit 29: Subscriptions are 81% of FY26E revenue
$6,438mFY26E revenueInsights80.5%$5,185mConferences11.1%$714mConsulting8.1%$520mOther (divested)0.3%$19m

Source: Penmark Research model, FY26E.

Exhibit 30: Three-fifths of revenue is earned in the US and Canada
US and CanadaEMEAOther internationalFY25 revenue62%26%12%

Source: Company FY25 10-K, rounded; other international derived as the remainder of $6.50bn.

PART 2 · THE BUSINESS · 7 THE MARKET AND COMPETITIVE POSITION

Gartner is the scale leader; AI tools, not rivals, are the threat

Gartner leads a small field of research rivals by scale and growth. The open question is whether AI tools take away the cheap end of what it sells.

Exhibit 31: Gartner has two close rivals, and the larger threat is substitutes, not peers
CompetitorWhere it overlapsWhat is different
ForresterSubscription research, advice and eventsClosest business model; contract value down 3.5%; 9M GAAP operating loss $12.9m
IDCTechnology research, market data, advisory, eventsStrong in quantitative market data and forecasts
Info-Tech Research GroupIT research, advisory and software reviewsPractical blueprints for completing IT projects
Everest Group, ISGProvider research, sourcing and governanceResearch is bundled with execution services
McKinsey, AccentureTechnology strategy and transformationProject advice, not recurring research subscriptions
Generative AI toolsAnswers to questions once taken to analystsThe question is whether answers are enough without proprietary data and expert calls

Source: Company websites and filings; Gartner 10-K; industry commentary to Nov 2026. Gartner's share of IT research and advisory spending is not published.

Exhibit 32: Gartner is about 18 times the size of Forrester by revenue
Gartner FY26EForrester 2026 guide (mid)ISG 2026 implied (mid)$6,438m$355m$256m

Source: Penmark Research model (Gartner); Forrester Q3 2026 release, guide $350m-$360m; ISG Q3 2026 release, implied $255.8m-$256.8m. Mixes of research, consulting and events differ.

Exhibit 33: Gartner's contract value is growing 2.5% while Forrester's is falling 3.5%
Gartner, Sep 2026Forrester, Sep 20262.5%−3.5%

Source: Gartner Q3 FY26 release; Forrester Q3 2026 release. Definitions differ slightly between the two companies.

How big is the market?

Gartner serves a much wider market than research alone. Gartner cites an addressable opportunity of about $200bn across technology, finance, HR, legal, marketing and sales. That is potential demand, not what clients spend on research today. Against it, $5.3bn of contract value is about 2.7%, but that is penetration, not market share.

What threatens it?

Artificial intelligence (AI) tools could make routine answers cheap. Barclays cut Gartner to Underweight on 6 November 2026, citing ex-federal contract value growth of 2.8% against the roughly 4% exit rate Gartner had flagged, a Q4 pickup to only about 3%, and low-single-digit growth in 2027. On the other side, Gartner's digital engagement and analyst inquiries both rose in Q2 and Q3 FY26 (engagement +140bp), and it sells its own AI interface, AskGartner.

What keeps clientsGartner's advantage is proprietary data, relationships with more than 13,000 enterprises and live access to analysts. Evidence that it lasts is wallet retention of 98% in technology and 99% in business, with a 3% price rise taking effect from 2 November 2026. The evidence against is that CV growth fell from 8% to 1% in a year, and no source isolates how much of that was AI.
PART 2 · THE BUSINESS · 8 MANAGEMENT, GOVERNANCE AND CAPITAL ALLOCATION

The CEO and CFO own $252m of stock, but pay is tied to contract value, not per-share profit

Exhibit 34: The CEO and CFO hold $252m of stock, and 86% of reported CEO pay is equity
ExecutiveTenureHow they are paidWhat they own
Eugene HallChairman and CEO22.3 yrsCEO since Aug 2004, chair since Jul 2024. Prior: Automatic Data Processing.$19.23m total, FY25
86% equity, 8% cash bonus. Bonus: EBITDA 50%, revenue 50%.
$234.4m 1.8%1,219,897 shares; 238x salary. No open-market trades in the Form 4 sample.
Craig SafianEVP and CFO12.4 yrsCFO since Jun 2014; 23+ years at Gartner. Prior: Headstrong.$6.52m total, FY25
75% equity, 13% cash bonus. Same bonus metrics.
$17.7m 0.1%92,253 shares; 25x salary. No open-market trades in the sample.
Scott HenselEVP, Global Services and Delivery6.0 yrsIn role since Nov 2020; joined 2017. Prior: Terex.$4.35m total, FY25
69% equity, 16% cash bonus. Same bonus metrics.
$6.1m 0.05%31,591 shares; 10x salary. No open-market trades in the sample.
Thomas KimEVP, Chief Legal Officer3.6 yrsIn role since Apr 2023. Prior: Thomson Reuters (chief legal officer).$3.86m total, FY25
65% equity, 18% cash bonus. Same bonus metrics.
$1.4m 0.01%7,236 shares; 2x salary. No open-market trades in the sample.
Robin KranichEVP, Chief HR Officer18.5 yrsIn role since May 2008; 31+ years at Gartner.$4.35m total, FY25
69% equity, 16% cash bonus. Same bonus metrics.
$5.6m 0.04%29,204 shares; 10x salary. Sold 3,278 shares at $196.50 ($0.64m) on 27 Aug 2026.
Salary and benefitsCash bonusEquity awards (value at grant)

Source: Proxy statement (DEF 14A) filed 15 Apr 2026 for FY25; SEC Form 4 filings, 7 Aug to 10 Nov 2026. Hensel and Kranich were granted identical awards in the proxy summary compensation table (stock $2.09m, options $0.90m, bonus $0.70m); totals differ only slightly and both round to $4.35m, so both show about 69% equity and 16% cash bonus. Holdings: proxy table at 2 Apr 2026 (67.5m shares) at $192.15 (13 Nov 2026), beneficial ownership. 2025 bonus paid at 119.6% of target; share awards earned at 82.1%.

Exhibit 35: Insiders sold $1.47m in three months and bought none
Kranich (CHRO)Genovese (EVP)Herkes (EVP)Fuchs (director)Jain (EVP)Purchases$0.64m$0.33m$0.20m$0.16m$0.14m$0.00m

Source: SEC Form 4 filings, 7 Aug to 10 Nov 2026 (open-market sales, code S). Sales may be pre-arranged; we draw no inference on intent.

Exhibit 36: Buybacks took 87% of the cash Gartner generated or raised in FY21 to FY25
Buybacks $6,032mCapex $488mOther $377m$6.9bn, FY21-2587%7%5%

Source: Company cash flow statements, FY21 to FY25: operating cash flow $6,345m plus FY25 debt raised $551m. Other is derived: acquisitions, FX and cash build.

Does pay reward per-share value?

Partly. Equity is 88% of CEO target pay (86% of reported pay), 70% of it in share units earned on contract value. No pay metric is per share. Units were earned at 82.1% for 2025, when CV grew 1.0% reported and 4.0% excluding US federal clients.

Governance

The board is independent, but one person is chair and CEO. 12 of 13 directors are independent. A clawback policy meets NYSE rules, and the CEO must hold shares worth six times salary.

What it means for valueGartner has put almost all its free cash into buybacks, cutting weighted diluted shares from 78.3m in FY24 to 66.8m for 9M FY26. Our model keeps that up, which lifts FY27E EPS 6.9% above consensus.
PART 2 · THE BUSINESS · 9 WHAT MOVES THE STOCK

The shares trade on contract value growth, which moves them more than the market does

The shares trade on contract value, not on the market or on earnings. Two drivers passed at least two of four tests, and both measure whether subscriptions are shrinking.

Exhibit 37: Two drivers pass at least two of four tests, and both are subscription health
What moves the stockTests passedMarket reaction against our model valueDebateNext number
Contract value growthThree of four testsEach 1pt of CV growth moved the shares 8.5% ($16) across all seven results days, 4.6% ($9) excluding 4 Aug 2026. Model: $15.29AI and the seat baseQ4 FY26 CV growth, Feb 2027
Technology wallet retentionTwo of four tests; retention vs price, correlation 0.86No clean results-day signal: the 4 Aug 2026 jump came with an EPS beat and guidance raise. Model: $15.29 if above 100%AI and the seat baseQ4 FY26 retention, Feb 2027

Source: Yahoo Finance daily closes, Nov 2024 to Nov 2026; Signals KPIs; Q&A tagged from eight call transcripts; Penmark Research model, 16 Nov 2026. Reaction is a regression slope on seven results days, so treat it as approximate.

Exhibit 38: Shares moved 4.6% to 8.5% for each point of change in CV growth on results days
−40%−20%0%20%40%−3−2−101Results-day share moveChange in CV growth since last quarter (pts)1Q252Q253Q254Q251Q262Q263Q26R² 0.42, n=7

Source: Yahoo Finance; Signals KPIs; results days 6 May 2025 to 3 Nov 2026 (seven events; the Feb 2025 print has no prior CV change). The 4 Aug 2026 move also carried an EPS beat and a guidance raise; without it the correlation falls from 0.65 to 0.47. The fit is Penmark analysis.

Exhibit 39: The sector explains 22% of daily moves and the market 8%; the rest is company-specific
Market onlySector onlyMarket and sectorMarket, sector and rates8%22%23%23%

Source: Yahoo Finance daily returns, 750 trading days to 17 Nov 2026; S&P 500, IGV software ETF, 10-year yield. R-squared = share of daily price variance explained.

Exhibit 40: Analysts asked most about the economy, then retention, then margins
Macro and layoffsRetention and renewalsMargins and hiringAI and substitutionUS federalBuybacksPricingOther119863326

Source: Signals call transcripts, eight calls from 4 Feb 2025 to 3 Nov 2026; 48 analyst question paragraphs tagged by Penmark Research.

Test results in brief

The share price follows CV growth, and more tightly than it follows the market. The level of quarter-end CV growth and the price have a correlation of 0.92 over eight quarters. On results days the correlation of the move with the change in CV growth is 0.65 (0.47 excluding 4 Aug 2026). Results days account for 35% of squared daily returns.

Retention questions came up nine times in 48. Our read: the stock trades on whether subscriptions are shrinking, not on earnings. EPS rose while the multiple fell.

PART 2 · THE BUSINESS · 9 WHAT MOVES THE STOCK (CONTINUED)

One point of extra contract value growth is worth $15 a share; results days imply $9 to $16

Each driver is a claim, with the market reaction, our model value and the next number.

Driver: contract value growth

The claim. CV growth, now 2.5%, will reach 3.0% in FY27E, and that is worth more than the price implies.

What the market does. On results days the shares moved about 8.5% per point of change in CV growth with all seven days (about $16 a share at $192.15), and about 4.6% (about $9) excluding 4 Aug 2026.

What our model says. One extra point of CV growth a year is worth $15.29 a share. Our $15.29 sits inside the $9 to $16 that results days imply.

Debate. The AI and seat base debate.

Next number. Q4 FY26 CV growth, Feb 2027. We expect 2.8%; consensus is not published. A 1pt miss costs about 4.6% to 8.5%.

Driver: technology wallet retention

The claim. Retention among technology clients has turned; our base case holds it near 98%, and passing 100% is the upside case.

What the market does. Retention fell from 102% to 96% and the shares fell with it; its level and the price have a correlation of 0.86 over eight quarters. The 22.6% jump on 4 Aug 2026 came with adjusted EPS of $4.37 against about $3.77 expected and a 2026 EPS guide raised to $14 from $13.25, so we do not credit retention.

What our model says. Retention back above 100% is our upside case, worth $15.29 a share. It overlaps with the CV growth driver and is not additive.

Debate. The AI and seat base debate.

Next number. Q4 FY26 retention, Feb 2027. Q3 was 98%; our model does not forecast it, and the company gives no guidance on it.

Exhibit 41: Five commonly cited drivers failed the tests
CandidateWhy we dropped it
Macro and layoffsMost-asked topic (11 of 48), but the market explains 8% of daily moves and no result day tracks it
US federal sales3 questions; federal is only 2-3% of CV, too small to explain a 13% move
Interest ratesAdding the 10-year yield lifts R-squared by only 0.2 points
Margins and hiring8 questions, but the FY26 EBITDA floor was raised three times and the shares still fell on 3 Nov 2026
Buybacks3 questions; they lift EPS, but the multiple change cost six times what earnings growth added

Source: Yahoo Finance; Signals call transcripts and KPIs; Penmark Research analysis.

Exhibit 42: One extra point of CV growth a year adds $15.29 to our base value
$0$100$200$300Base valueCV growth +1.0ptBase plus 1pt$243+$15$258

Source: Penmark Research model, 16 Nov 2026; FY27E-FY35E CV growth shifted by 1.0pt.

Exhibit 43: Four inputs each move value by $19 to $41 a share, led by the discount rate
Discount rateCV growthTerminal growthEBITDA marginBase $243+0.5pt −$19−0.5pt +$22−1.5pt −$21+1.0pt +$152.0% −$144.0% +$19−1.0pt −$12+0.6pt +$7

Source: Penmark Research model, 16 Nov 2026; base case valued at 13 Nov 2026; each input changed alone.

PART 3 · THE THESIS · 10 CONTRACT VALUE

Contract value growth is recovering, and the price assumes it is not

THESIS 1 · THE CLAIMContract value growth has turned, and pricing and steadier retention take it from 2.5% to about 3% in FY27E

What the market believes

The price implies CV growth averages about −0.3% a year to FY35E. Consensus FY27E revenue is $6,670m, which needs a recovery to near 4.5% by the end of FY27.

The evidence

  • Reported data. CV growth rose from 1.0% to 2.5% in two quarters, and Q3 is the second rise in a row.
  • KPIs. Technology wallet retention rose from 96% to 98%. Business wallet retention held at 99%.
  • Calls. Management expects total CV growth to keep rising through year-end. Ex-federal growth is unlikely to reach 4% in 2026.
Exhibit 44: Business-sales CV growth has steadied and technology is recovering
Technology sales (GTS)Business sales (GBS)0.0%2.5%5.0%7.5%10.0%12.5%4Q241Q252Q253Q254Q251Q262Q263Q262%4%

Source: Signals KPIs from company supplements, Dec 2024 to Sep 2026. Growth is y/y, FX-neutral.

Exhibit 45: Our FY27E revenue is 1.1% below consensus: we model 3.0% year-end CV growth, consensus implies about 4.5%
US$mFY26EFY27E
Revenue excl. divested, Penmark6,4196,593
Revenue, consensus6,4306,670
Difference−0.2%−1.1%
Contract value growth, Penmark2.8%3.0%

Source: Yahoo Finance consensus, 16 Nov 2026; Penmark Research model. Consensus CV growth is not published.

What it is worth

CV growth of 3.0% in FY27E, 4.0% in FY29E-FY31E, fading to 3.0% by FY35E gives a base value of $243.01 a share. One extra point a year adds $15.29. At the market view, 1.5 points lower, the value is $221.87.

Signposts

  • Feb 2027. Q4 FY26 CV growth at or above 2.8% confirms; below 2.5% disproves.
  • May 2027. Q1 FY27 near 3%, from the 3% price rise (effective 2 Nov 2026) and steadier retention.
Exhibit 46: Total CV growth is closing on the ex-federal rate, which has slowed to 2.8%
Total CV growthExcluding US federal0%1%2%3%4%Q4 FY25Q2 FY26Q3 FY261.0%4.0%1.7%3.3%2.5%2.8%

Source: Company calls, Q4 FY25, Q2 FY26 and Q3 FY26 (3 Nov 2026). Federal is 2% to 3% of CV.

What would prove us wrongCV growth below 2.5% in the Q4 FY26 result, due in February 2027, would break the claim.
PART 3 · THE THESIS · 11 CAPITAL RETURN

Buybacks lift EPS well above revenue growth, and consensus under-models them

THESIS 2 · THE CLAIMBuybacks, not growth, lift EPS by 16% a year, and the cash can pay for them

What the market believes

Consensus FY27E EPS of $16.36 implies about 61.7m shares, against our 58.3m, so it assumes less buying. The price implies 11.0x FY27E earnings.

The evidence

  • Reported data. Weighted diluted shares fell from 78.3m in FY24 to 66.8m for 9M FY26, after $1.99bn of buybacks in FY25.
  • Cash. Free cash flow (FCF) was 144% of net income in the first nine months of FY26, so buybacks are funded by operations.
  • Calls. Management guides to a three-year EPS growth rate above 12% from FY25, a floor of $18.50 for FY28.
Exhibit 47: Fewer shares add $6.29 of the $7.39 rise in EPS from FY25A to FY28E
$0$5$10$15$20$25FY25A adjustedEPSFewer sharesHigher adjustednet incomeFY28E adjustedEPS$13.17+$6.29+$1.10$20.57

Source: Penmark Research model: adjusted net income $996m on 75.6m shares (FY25A) and $1,052m on 51.2m shares (FY28E). Split is Penmark arithmetic.

Exhibit 48: We are 6.9% above consensus on FY27E EPS, and the share count is the reason
Per shareFY26EFY27E
Adjusted EPS, Penmark15.1917.49
Adjusted EPS, consensus14.9916.36
Difference+1.3%+6.9%
Diluted shares, Penmark (m)65.958.3
Share count, consensus (m)–~61.7

Source: Yahoo Finance consensus, 16 Nov 2026; Penmark Research model. Consensus share count is implied by consensus EPS and net income.

What it is worth

Of the $1.13 FY27E gap to consensus, fewer shares add $0.95. Shares are 58.3m against about 61.7m. Net income adds $0.18 ($1,019m vs about $1,009m): our 25.4% margin offsets revenue $77m below consensus.

Signposts

  • Feb 2027. A FY27 share count guide near 58m confirms; above 62m disproves.
  • Each quarter. Repurchases of at least $400m.
Exhibit 49: Buybacks exceed free cash flow until cash reaches $600m in FY28E
Share buybacks, $mFree cash flow, $m$0$500$1,000$1,500$2,000FY24AFY25AFY26EFY27EFY28EActualEstimates

Source: Company filings (A); Penmark Research estimates (E). FY26E buybacks include $400m in Q4.

What would prove us wrongBuybacks lift EPS but are value-neutral in our DCF; value rests on contract value. Buybacks below $1bn a year would cut FY28E EPS of $20.57 toward the $18.50 floor.
PART 4 · THE NUMBERS · 12 FORECASTS

Our forecasts rest on contract value growth, and every FY26E line clears guidance

The forecast starts with contract value, the one number that drives the subscription arm. Everything else follows from it, from the 3.0% in FY27E to the 4.0% peak in FY29E to FY31E.

Exhibit 50: FY27E revenue of $6,593m is contract value growth with a ratable lag, plus events and consulting
CV growth, year-end3.0% (FY26E 2.8%)Revenue vs CV gap−0.8pt a yearInsights$5,294m, 80% of revenueEvents and attendance55 events in FY26Growth+7.0% (FY26E +10.7%)Conferences$764m, +7.0%Backlog$217m, +9% y/yGrowth+3.0% (FY26E −5.9%)Consulting$536m, +3.0%Revenue FY27E$6,593m, +2.7% y/y

Source: Penmark Research model, FY27E. Highlighted box is the driver that matters most; the revenue gap is the lag between contract value and recognised revenue.

Exhibit 51: Our FY26E clears every guidance floor, by 0.2% on revenue to 3.7% on EPS
Revenue $6,419m vs$6,405mAdj. EBITDA $1,635m vs$1,615mAdj. EPS $15.19 vs $14.65Free cash flow $1,240m vs$1,235m+0.2%+1.2%+3.7%+0.4%

Source: Company Q3 FY26 call, 3 Nov 2026 (guidance floors, ‘at or above’; revenue and EBITDA exclude the divested unit); Penmark Research model, 16 Nov 2026. Percent = Penmark FY26E over the floor.

Exhibit 52: Value per share spans $217 to $271 across CV growth and margin shifts
$217$224$231$238$246$223$230$237$244$252$229$236$243$251$258$234$242$249$257$265$240$248$255$263$271CV growth shift, FY27E-FY35E−1.0pt−0.5pt0+0.5pt+1.0ptEBITDA margin shift−1.0pt−0.5pt0+0.5pt+1.0pt

Source: Penmark Research model, 16 Nov 2026; base case valued at 13 Nov 2026 (Sensitivities).

Revenue, costs and cash

Revenue grows 2.7% in FY27E and 3.4% by FY30E, as contract value growth rises to 4%. Insights revenue lags contract value because subscriptions are recognised evenly over the year.

Margin edges up from 25.4% to 26.0% by FY29E. Stock pay is 2.6% of revenue, depreciation 1.5% to 1.6% and capex 1.5%. Analyst rehiring is the main cost pressure.

Free cash flow stays near 19% of revenue. Deferred revenue adds $79m in FY27E. The model holds $3.0bn of debt and $600m of cash from FY28E.

Where we differ from consensus

  • Revenue, FY27E, −1.1%. We assume CV growth of 3.0% at year-end; consensus implies about 4.5%.
  • EBITDA, FY27E, −0.3%. Our margin is 25.4% against 25.2% for the Street, which offsets lower revenue.
  • EPS, FY27E, +6.9%. We use 58.3m shares; consensus implies about 61.7m.
PART 4 · THE NUMBERS · 13 VALUATION

Two methods put fair value at $243 to $262 a share, against a $192.15 price

We value Gartner two ways. A ten-year cash flow model sets the base value, and a peer-based earnings multiple checks it.

Exhibit 53: Both methods sit above the price; only the bear case sits below it
DCF, bear to bullBase DCF, discount rate ±1ptBase DCF, terminal growth 2%to 4%FY27E P/E 14x to 16xStreet targets, low to high$100$150$200$250$300$350$133.40$315.65$208.14$291.13$229.02$262.20$244.86$279.84$170.00$231.00Price $192.15Target $247.12

Source: Penmark Research model, 16 Nov 2026; values at 13 Nov 2026; target is the 12-month value; Street targets: S&P Global via StockAnalysis, page updated 9 Nov 2026 (15 analysts).

Exhibit 54: 70% of weight is above the price
$0$100$200$300$400$133.40$243.01$315.65Bear30%Base50%Bull20%Weighted $224.66

Source: Penmark Research model, 16 Nov 2026. Price $192.15; weighted value $224.66.

Exhibit 55: The base DCF gives $243.01 a share, and half of it comes after FY35E
DCF, US$mBase case
PV of FY26E-FY35E cash flows8,175
PV of terminal value9,035
Enterprise value, 30 Sep 202617,210
Less: debt, deferred comp. and $500m operating cash, net of cash−1,874
Equity value15,336
Diluted shares (m)63.838
Value per share, 30 Sep 2026$240.23
Value per share, 13 Nov 2026$243.01
Terminal value share of EV52.5%

Source: Penmark Research model, 16 Nov 2026. Weighted average cost of capital (WACC) 9.17%; terminal growth 3.0%; return on new invested capital 20%.

Why a DCF is the main method

A one-year multiple cannot tell a 2% to 3% growth trough from a decline. A discounted cash flow (DCF) values the cash the business will produce over ten years. We use free cash flow after stock pay, FY26E to FY35E.

WACC is the blended return investors need from debt and equity. Terminal growth is the steady rate cash flow grows after FY35E.

The cross-check

FY27E EPS of $17.49 at 15.0x gives $262.35, 8.0% above the DCF. The multiple is the peer lower-quartile P/E of 18.8x less 20% for slower organic growth. The gap is under 15%, so the DCF stays the anchor.

Exhibit 56: Gartner earns twice the peer return on capital and trades 51% below the peer P/E
PeersGartnerPeer medianDifference
P/E, next twelve months12.1x24.4x−51%
Revenue growth, 3-year CAGR3.0%6.4%−3.5pp
Adjusted EPS growth, 3-year CAGR16.3%11.2%+5.1pp
Return on invested capital34.0%17.9%+16.1pp
Beta0.910.96−0.05

Source: S&P Global via StockAnalysis, 13 Nov 2026; Penmark Research model. Peer median P/E shown at the last close; target P/E applies a 20% discount to the 18.8x lower quartile.

PART 4 · THE NUMBERS · 13 VALUATION (CONTINUED)

The price assumes Gartner shrinks forever, and the target needs only modest growth

Exhibit 57: Base value stays above the price at every discount rate and growth rate tested
$269$279$291$306$324$247$255$265$276$290$229$236$243$252$262$213$218$224$231$239$199$203$208$214$220Terminal growth2.0%2.5%3.0%3.5%4.0%Discount rate8.17%8.67%9.17%9.67%10.17%

Source: Penmark Research model, 16 Nov 2026; base case valued at 13 Nov 2026 (Scenarios).

Exhibit 58: The price needs terminal growth of −3.0%, where we use +3.0%
What the price impliesOur modelTerminal growthDiscount rateCV growth FY27E-35E,avg−3.03.09.210.7−0.33.6

Source: Penmark Research model, 16 Nov 2026 (Market Check). Each solve changes one input and holds the others at base. Values in percent.

Exhibit 59: The $247.12 target is the weighted value plus carry, and it clears the Buy bar by 18.6pp
ReconciliationUS$/share
Probability-weighted value, 13 Nov 2026$224.66
Add: 12-month carry at 10.0% cost of equity+$22.47
12-month price target$247.12
Share price, 13 Nov 2026$192.15
Total return to target (rating basis)+28.6%
RatingBuy

Source: Penmark Research model, 16 Nov 2026. Buy needs a total return above +10%. Carry is the expected price gain at the cost of equity; no dividend is paid.

What the price implies

A reverse DCF asks what the market must believe to justify today’s price. At $192.15 it needs contract value to shrink about 0.3% a year to FY35E. That is a worse outcome than 1.5pt lower growth, our AI bear driver.

Weights are our judgment, not measured odds. Hold needs a 59.7% bear weight.

Exhibit 60: The bear case is the only scenario that would be rated Sell
CaseWeightValue12-monthReturnWhat has to happen
Bear30%$133.40$146.74−23.6%CV growth falls to −1.5% by FY29E; margin 22%
Base50%$243.01$267.31+39.1%CV growth 3.0% in FY27E, 4.0% in FY29E-FY31E, fading to 3.0% by FY35E; margin 26%
Bull20%$315.65$347.22+80.7%Retention above 100%; CV growth 6.5% by FY29E; margin 28%

Source: Penmark Research model, 16 Nov 2026. Return is from $192.15 to each case’s 12-month value.

Exhibit 61: Value gap of $32.51 plus carry of $22.47 lifts $192.15 to the $247.12 target
$0$50$100$150$200$250Price, 13 Nov2026Return to value12-month carry12-month target$192+$33+$22$247

Source: Penmark Research model, 16 Nov 2026.

Exhibit 62: At our target Gartner would still trade at 14.1x earnings, below the 24.4x peer median
FY27EAt $192.15At target
P/E, adjusted11.0x14.1x
EV / adjusted EBITDA8.1x10.2x
FCF yield10.3%8.0%
Peer median NTM P/E24.4x24.4x

Source: Penmark Research model, 16 Nov 2026; S&P Global via StockAnalysis, 13 Nov 2026 (peer P/E).

PART 4 · THE NUMBERS · 14 CATALYSTS AND RISKS

Retention is the largest prize, and AI substitution is the largest risk

Exhibit 63: Four results in the next twelve months test the call, starting with the February guide
Feb 2027Q4 FY26 results and FY27outlookMay 2027Q1 FY27: CV growth near3%Aug 2027Q2 FY27: GTS retentionNov 2027Q3 FY27: first read on 3%price rise

Source: Company calls, 3 Nov 2026 and earlier years; result dates are expected from prior-year timing and are not confirmed.

Exhibit 64: AI substitution and rates are the two costliest risks; retention is the biggest prize
CV growth +1.0ptAI advisory demand +0.5ptCost discipline +0.6ptmarginConferences +2.0ptFederal +0.3ptLayoffs and Gulf conflict−0.5ptMargin reset −1.0ptRates +0.5ptAI substitution −1.5pt$15.29$7.52$7.24$2.67$1.01−$2.72−$12.07−$18.72−$21.14

Source: Penmark Research model, 16 Nov 2026; base case $243.01 valued at 13 Nov 2026; each catalyst changed alone.

What would change the rating

The rating moves to Hold if the share price rises above $224.66, at an unchanged $247.12 target. It moves to Sell only if the price rises above $274.58 or the target falls below $172.94.

The bear case would need a 59.7% weight, from 30% today, to turn the rating to Hold. The thesis ends if contract value growth falls below 2.5% in the February result and the outlook cuts margins.

Exhibit 65: Each result has a Penmark expectation set against the Street
DateEventPenmark expectsStreet
Feb 2027Q4 FY26 and FY27 outlookCV growth 2.8% or better; EBITDA margin 25.4%Consensus FY27 margin 25.2%
May 2027Q1 FY27CV growth near 3% from pricing and steadier retentionConsensus FY27 revenue $6,670m
Aug 2027Q2 FY27GTS wallet retention near 98%; above 100% is the bull casePartly priced in consensus
Nov 2027Q3 FY27First full year of the 3% price rise; 12-month target dateConsensus FY27 EPS $16.36

Source: Penmark Research model, 16 Nov 2026; Yahoo Finance consensus (revenue, EPS), 16 Nov 2026; MarketScreener (EBITDA), 21 Oct 2026.

Exhibit 66: Four risks cost $2 to $21 a share; the main upside adds $15
RiskLikelihoodValueChange tested
Generative AI replaces core research seats35%−$21.14CV growth 1.5pt lower each year
Long rates stay above 5%30%−$18.72Discount rate 0.5pt higher
FY27 outlook resets margins30%−$12.07EBITDA margin 1.0pt lower
Tech layoffs and Gulf conflict cut renewals45%−$2.72CV growth 0.5pt lower to FY28E
Upside risk: retention returns above 100%35%+$15.29CV growth 1.0pt higher

Source: Penmark Research model, 16 Nov 2026. Likelihoods are our judgment. Values are changes to the $243.01 base case.

PART 4 · THE NUMBERS · 15 OWNERSHIP AND TRADING

Gartner is held by index and value funds, and the Street is mostly neutral

Exhibit 67: Vanguard and BAMCO are the largest of the 670 holders filing 13Fs, with 7.9m and 6.4m shares
VanguardBAMCOBlackRockIndependent FranchiseAQRState StreetGeodeHarris AssociatesInvescoMorgan Stanley7.9m6.4m5.0m4.9m4.1m2.6m2.5m2.0m2.0m1.8m

Source: SEC Form 13F filings, positions at 30 Sep 2026: ten largest of 670 13F filers by shares. BAMCO is an affiliate of Baron. As-of dates differ: BlackRock holds 5.0m shares at 30 Sep 2026 (13F) against 7.3m (10.8%) at 2 Apr 2026 (proxy). Totals can double-count shared positions, so we show no ownership percentages.

Exhibit 68: Four holders owned over a third of shares at the proxy date, and insiders 2.6%
Vanguard 14.2%BlackRock 10.8%Baron 6.4%Capital Intl 6.1%Directors and officers 2.6%Shares at 2 Apr 202614.210.86.46.12.6

Source: Proxy statement (DEF 14A) filed 15 Apr 2026; 67,510,191 shares outstanding at 2 Apr 2026. Holders of more than 5% report to the SEC.

Exhibit 69: Ten of fifteen analysts say Hold, and only two say Buy
BuyHoldSellStreet ratings2103

Source: S&P Global via StockAnalysis, page updated 9 Nov 2026, so it already includes Truist (4 Nov) and Barclays (6 Nov): 2 Strong Buy, 10 Hold, 2 Sell, 1 Strong Sell.

Exhibit 70: Our $247.12 target sits above the highest Street target of $231
Street low $170Street mean $201Penmark $247Price $192Street high $231

Source: S&P Global via StockAnalysis, page updated 9 Nov 2026, 15 analysts (same pull as Exhibit 69); Penmark Research model, 16 Nov 2026 (target and price at 13 Nov 2026).

What the holder list tells us

The 13F register is concentrated in index and value funds. Vanguard and BlackRock are index managers. BAMCO, Independent Franchise and Harris Associates are value-style managers.

Exhibit 71: About a tenth of shares are sold short, which can amplify a move either way
Trading and positioningValue
Short interest, 30 Oct 20266.29m shares
Share of shares outstandingabout 9.9%
Days to cover5.8
Average daily value traded, 3 months$219m
52-week closing range$125.73 to $254.59
Open-market insider sales, Aug to Nov 2026$1.47m
Open-market insider purchasesnone

Source: FINRA, 30 Oct 2026; Yahoo Finance, 13 Nov 2026; SEC Form 4 filings, 7 Aug to 10 Nov 2026.

Short interest and the Street

Short sellers cut their bets by 24% during the October rally. The stock then fell 13.2% on 3 November, so the next result can move it sharply either way.

The Street is cautious ahead of February. Truist moved to Hold on 4 November and Barclays to Underweight on 6 November. Our target is above every Street target.

What it means for valueInsiders sold $1.47m of stock in three months and bought none. The sums are small against the $234m held by the CEO alone, and we draw no view on value from them.
PART 4 · THE NUMBERS · 16 TRACK RECORD AND QUALITY OF NUMBERS

Growth has slowed to 3.7%, and FY25 adjusted profit was well above GAAP

Exhibit 72: Revenue growth has slowed from 15.7% to 3.7% while the adjusted EBITDA margin eased to 24.8%
Revenue growth, %Adjusted EBITDA margin, % (right)0510152024.525.025.526.026.527.0FY22AFY23AFY24AFY25A

Source: Company filings, FY22 to FY25; growth on reported revenue including the divested operation. FY22 growth uses FY21 revenue of $4,734m.

Exhibit 73: Free cash flow covered net income 1.6 times in FY25 because of non-cash charges
Free cash flow as % of net incomeStock pay as % of revenue (right)0501001502001.61.82.02.22.42.6FY22AFY23AFY24AFY25A

Source: Company cash flow statements and income statements, FY22 to FY25. Free cash flow is operating cash flow less capex.

Exhibit 74: Adjusted EPS of $13.17 was 36% above GAAP EPS of $9.65 in FY25
Adjusted EPS, $Diluted GAAP EPS, $$0$5$10$15$20FY24AFY25A$14.09$16.00$13.17$9.65

Source: Company filings. FY24 GAAP EPS includes a $300m insurance gain; FY25 includes $229m of impairments and other items. Adjusted EPS is company-defined.

Exhibit 75: The gap between adjusted and GAAP earnings flipped from negative to $3.52 in FY25
Adjusted to GAAPFY24AFY25A9M FY26A
Adjusted EPS$14.09$13.17$11.28
Diluted GAAP EPS$16.00$9.65$10.66
Gap, adjusted less GAAP−$1.91+$3.52+$0.62
Amortisation, $m90.282.360.1
Impairments, $m0229–
Gain on divestiture, $m006.8
Insurance gain, $m300.000

Source: Company filings (10-K FY24 and FY25, 10-Q Q3 FY26) and releases; Penmark Research model, 16 Nov 2026.

Quality of earnings

Adjusted EPS excludes $82m of acquired-intangible amortisation and $229m of FY25 charges; stock pay stays in as a cost. Adjusted EBITDA adds stock pay back, so our DCF deducts it separately ($171m in FY27E).

FY24 GAAP profit was flattered by a $300m insurance gain. That is why GAAP EPS of $16.00 sat above adjusted EPS in that year.

Accounting choices to watch

  • Deferred revenue. It adds $79m to FY26E free cash flow, so FCF excluding it is $1,161m.
  • Buybacks. Equity turned negative, to −$35m, in September 2026, because repurchases exceed retained profit.
PART 5 · APPENDIX · 17 FINANCIAL MODEL

The model has revenue growing 2.4% to 3.4% a year while EPS compounds at 14% to 18%

Exhibit 76: Free cash flow stays near 19% of revenue while buybacks shrink the share count by about 11% a year
Annual modelFY25AFY26EFY27EFY28EFY29EFY30EFY31EFY32EFY33EFY34EFY35E
Income statement, US$m
Insights revenue5,0735,1855,2945,4245,5845,7625,9476,1306,3036,4656,615
Conferences revenue6457147648108548979379751,0141,0491,086
Consulting revenue552520536554574594615636655675695
Total revenues6,4976,4386,5936,7887,0127,2537,4997,7417,9728,1898,397
Revenue growth excl. divested5.0%2.4%2.7%2.9%3.3%3.4%3.4%3.2%3.0%2.7%2.5%
Adjusted EBITDA1,6111,6401,6751,7441,8231,8861,9502,0132,0732,1292,183
Adj. EBITDA margin excl. divested25.2%25.5%25.4%25.7%26.0%26.0%26.0%26.0%26.0%26.0%26.0%
Stock-based compensation156171171176182189195201207213218
Operating income1,0261,2921,3191,3851,4581,5681,6421,6951,7461,7931,839
Interest expense, net−61−88−91−113−142−156−172−178−178−178−178
Net income7299439579921,0261,1011,1461,1831,2231,2601,295
Adjusted net income9969991,0191,0531,0871,1171,1461,1831,2231,2601,295
Diluted shares, average (m)75.665.958.351.245.541.036.832.929.225.822.6
Adjusted EPS, US$13.1715.1917.4920.5723.9127.2831.1735.9941.8448.8057.21
Adjusted EPS growth−6.5%15.3%15.2%17.6%16.3%14.1%14.3%15.5%16.2%16.6%17.2%
Diluted EPS, US$9.6514.3216.4319.3822.5726.8931.1735.9941.8448.8057.21

Source: Company filings (FY25A); Penmark Research model, 16 Nov 2026 (estimates shaded). Fiscal year ends 31 December. FY26E includes $19.4m revenue from the divested operation; later years exclude it. FY27E growth is 2.4% including it in the FY26E base and 2.7% excluding it.

Exhibit 77: Equity stays negative because buybacks exceed profit, and net debt is held at $2.4bn from FY28E
Cash flow and balance sheetFY25AFY26EFY27EFY28EFY29EFY30EFY31EFY32EFY33EFY34EFY35E
Cash flow, US$m
Cash from operating activities1,2901,3251,3641,4081,4571,4891,5251,5711,6171,6591,700
Capital expenditure−115−85−99−102−105−109−112−116−120−123−126
Free cash flow1,1751,2401,2651,3061,3511,3801,4131,4551,4971,5361,574
Free cash flow / net income161.2%131.5%132.2%131.7%131.7%125.3%123.2%122.9%122.4%121.9%121.5%
Share repurchases, gross1,9911,6201,6931,6891,3381,3671,3991,4401,4821,5211,558
Balance sheet, US$m
Cash1,7231,4451,000600600600600600600600600
Deferred revenues2,8102,8892,9673,0543,1553,2643,3743,4833,5873,6853,778
Long-term debt, net of fees2,9772,9812,9812,9812,9812,9812,9812,9812,9812,9812,981
Stockholders' equity (deficit)320−163−744−1,282−1,424−1,515−1,586−1,656−1,723−1,786−1,846
Net debt (principal less cash)1,2821,5552,0002,4002,4002,4002,4002,4002,4002,4002,400
Gross debt / adjusted EBITDA1.87x1.83x1.79x1.72x1.65x1.59x1.54x1.49x1.45x1.41x1.37x

Source: Company filings (FY25A); Penmark Research model, 16 Nov 2026. Net debt is principal less cash; the model holds $3.0bn of debt and $600m of cash from FY28E.

PART 5 · APPENDIX · 17 FINANCIAL MODEL (QUARTERS AND SEGMENTS)

Eight quarters show stable Insights revenue and contract value growth turning up

Exhibit 78: Contract value growth has risen two quarters running, from 1.0% to 2.5%
US$m unless statedQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Insights revenue1,2471,2561,2641,2711,2831,2941,2901,292
Conferences revenue25173211752867824486
Consulting revenue153140156124134119142126
Other (divested)64665655501900
Total revenues1,7151,5341,6861,5241,7531,5111,6761,505
Adjusted EBITDA417385443347436400466364
Adjusted EPS, US$5.452.983.532.763.943.324.373.59
Free cash flow311––269271371378275
Operating KPIs
CV growth, FX-neutral8.0%7.0%4.9%3.0%1.0%1.0%1.7%2.5%
CV growth excl. US federal––––4.0%–3.3%2.8%
Technology wallet retention102.0%101.0%99.0%98.0%96.0%97.0%97.0%98.0%
Business wallet retention106.0%105.0%104.0%102.0%99.0%98.0%99.0%99.0%

Source: Company earnings releases, 10-Q filings and calls, Q4 FY24 to Q3 FY26. Technology (GTS) and Business (GBS) are the two client groups.

Exhibit 79: Insights revenue is steady near $1.3bn a quarter, and Conferences drives the seasonal swing
Insights, $mConferences, $mConsulting, $m$0$500$1,000$1,500$2,000Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26$1,651$1,468$1,631$1,469$1,703$1,492$1,676$1,505

Source: Company earnings releases and 10-Q filings, Q4 FY24 to Q3 FY26. Excludes the divested operation. Conferences peaks in Q2 and Q4.

Exhibit 80: Insights is 80% of revenue and Conferences is the fastest-growing segment
US$mFY23AFY24AFY25AFY26EFY27E
Insights4,5164,8295,0735,1855,294
Conferences505583645714764
Consulting515559552520536
Other (divested)371297227190
Total revenues5,9076,2676,4976,4386,593

Source: Company filings (A); Penmark Research model, 16 Nov 2026 (E). FY26E includes $19.4m from Digital Markets, sold 5 Feb 2026.

Exhibit 81: Insights earns 88% of segment gross contribution
Gross contribution, US$mFY24AFY25A9M FY26A
Insights$3,696.8$3,890.2$3,013.8
Conferences$281.4$322.8$205.6
Consulting$203.3$186.4$133.3
Insights share of total88.4%88.4%89.9%

Source: Company 10-K FY25 segment note and 10-Q Q3 FY26. Share is Insights over the three segments shown.

PART 5 · APPENDIX · 18 REFERENCE

Adjusted profit differs from reported by up to $267m, and every adjustment is company-defined

Exhibit 82: Adjusted net income was $267m above reported in FY25 and $151m below in FY24
US$m unless statedFY24AFY25A9M FY26A
Adjusted net income1,103996753
Net income, as reported1,254729712
Adjusted less reported−151+267+41
Adjusted EPS, US$14.0913.1711.28
Diluted EPS, as reported, US$16.009.6510.66
Adjusted EBITDA1,5561,6111,230
Operating income, as reported1,1561,026976

Source: Company filings and earnings releases; Penmark Research model, 16 Nov 2026. Adjusted measures follow the company definitions.

Peer set

Verisk (VRSK), FactSet (FDS), S&P Global (SPGI), Moody’s (MCO), MSCI (MSCI), Thomson Reuters (TRI), Broadridge (BR) and Morningstar (MORN). Forrester is excluded as an anchor because its earnings are near zero.

Data sources and dates

Company filings: 10-K FY25 (filed 12 Feb 2026), 10-Q Q3 FY26 and proxy statement (15 Apr 2026). Earnings releases and calls to 3 Nov 2026. SEC Forms 4 to 10 Nov 2026 and Forms 13F at 30 Sep 2026. Yahoo Finance prices to 17 Nov 2026, with the model price of $192.15 at 13 Nov 2026; S&P 500 +12.2% is Yahoo Finance weekly closes, 14 Nov 2025 to 13 Nov 2026. Street ratings and targets: S&P Global via StockAnalysis, page updated 9 Nov 2026. Consensus revenue and EPS from Yahoo Finance, 16 Nov 2026; EBITDA from MarketScreener, 21 Oct 2026. Peer data from S&P Global via StockAnalysis. Penmark Research model dated 16 Nov 2026.

Methodology note

Archetype: recurring revenue. Insights subscriptions are 81% of revenue excluding the divested unit; contracts are billed up front and over three-quarters run multiple years. We value Gartner with a ten-year discounted cash flow after stock pay, cross-checked with FY27E adjusted EPS at 15.0x. The target is the probability-weighted value of the bear, base and bull cases at 13 Nov 2026 plus twelve months of carry at the 10.0% cost of equity.

The model uses 63.838m diluted shares at 30 Sep 2026. Debt is deducted at principal. Consensus FY27E EBITDA was dated 21 Oct 2026, before the 3 November guidance raise.

Glossary and ratio definitions

Contract value (CV)
The annualised value of subscription contracts. It is the main operating measure.
Wallet retention
The share of last year’s client spending still held this year, including upgrades and cancellations.
Technology (GTS) and Business (GBS)
The two client groups: technology leaders and business leaders such as finance and marketing.
Free cash flow (FCF)
Operating cash flow less capital spending.
Adjusted EBITDA
Earnings before interest, tax, depreciation and amortisation, as the company defines it.
WACC
Weighted average cost of capital: the blended return investors need from debt and equity.
Terminal growth
The steady rate cash flow grows after the last forecast year.
Reverse DCF
A discounted cash flow solved backwards for what the price implies.
ROIC
Return on invested capital: operating profit after tax over capital invested.
P/E; EV/EBITDA
Share price over earnings per share; enterprise value over EBITDA.
PART 5 · APPENDIX · 18 DISCLOSURES

Analyst certification and important disclosures

Ratings

Ratings are based on the total return from the share price to our 12-month price target, including dividends (Gartner pays none). The price target is weighted across bull, base and bear scenarios.

BuyTotal return to price target above +10%
HoldTotal return to price target from −10% to +10%, inclusive
SellTotal return to price target below −10%

We review ratings at each set of results and whenever the facts change materially. A share price can move outside its band before the rating changes, and targets may not be reached.

Analyst certification

The Penmark Team certifies that (1) the views in this report accurately reflect its views about the subject company and its securities, and (2) no part of its compensation was, is or will be directly or indirectly related to the specific ratings, price targets or views in this report.

Contact

Penmark Research

Questions about our research:
research@penmarkresearch.com

All our research and coverage:
penmarkresearch.com

Basis of preparation

This report uses information publicly available up to its publication date. Share prices are closing prices on the trading day before the publication date, unless stated otherwise. Forecasts, valuations and price targets are Penmark Research’s own, and forecast periods are marked E. Sources are shown beneath each exhibit.

Valuation and price targets

Price targets are based on the valuation methods set out in each report and are weighted across bull, base and bear scenarios. The main risks to each rating and price target are described in the report. Penmark Research updates its coverage after each set of results but is not obliged to update a report at any other time.

Independence and conflicts of interest

Penmark Research is independent. It does not provide investment banking, brokerage, market-making or asset management services, does not trade securities, and does not accept payment from any company for research coverage. Companies do not see or review Penmark Research reports before publication.

No member of the Penmark Team holds a long or short position, directly or through derivatives, in the securities of any company Penmark Research covers.

Regulatory status

Penmark Research publishes general, impersonal investment research on a regular basis. It is not registered as an investment adviser with the US Securities and Exchange Commission or any state securities authority, is not a registered broker-dealer and is not a member of FINRA. Penmark Research does not give advice tailored to any person’s circumstances.

Not investment advice or an offer

This report is for information only. It is not personalised investment advice and is not an offer or solicitation to buy or sell any security or other financial instrument. It does not take into account any reader’s objectives, financial situation or needs. Readers should make their own investment decisions and seek independent professional advice where appropriate.

Forward-looking statements and risk

Forecasts, valuations and price targets are estimates based on assumptions that may prove wrong, and they may not be achieved. Opinions are current as of the publication date and may change without notice. Investing in equities involves risk, including the loss of capital. Share prices can be volatile, and past performance is not a reliable indicator of future results.

Data and sources

Company financials, operating data and filings come from company filings, earnings releases and earnings calls. Market data and any consensus estimates come from third-party sources named beneath the relevant exhibit; consensus figures from aggregators are unofficial. Penmark Research does not use other brokers’ research. Third-party data belong to their providers and may not be extracted from this report.

Accuracy and liability

Information is taken from sources believed to be reliable, but Penmark Research makes no representation or warranty as to its accuracy, completeness or timeliness. To the fullest extent permitted by law, Penmark Research accepts no liability for any loss arising from use of this report. Descriptions of litigation and regulatory matters reflect allegations and public records, not findings, unless stated. If a published report is corrected, the corrected version carries an “Updated” date at penmarkresearch.com.

Distribution and access

Penmark Research reports are available to registered users of penmarkresearch.com. Downloads and programmatic access are governed by the Penmark Research subscription terms. This report is not directed at, or intended for, any person in Singapore or India, and access from those countries is blocked. It is not intended for distribution to, or use by, any person in any jurisdiction where that would be contrary to law or regulation or would subject Penmark Research to registration or licensing requirements there.

Copyright and permitted use

© Penmark Research. All rights reserved. Penmark Research is a trade name of Brightriver Labs. Readers may share a link to this report but may not copy, reproduce, redistribute, sell or use its content, including for text and data mining, without written consent. Contact: research@penmarkresearch.com.

Keep reading

Sign in to Penmark